Honored and delighted that my lab's review "KRAS: Biology, Inhibition, and Mechanisms of Inhibitor Resistance" won the Distinguished Paper Award from Current Oncology! www.mdpi.com/about/announ...

Ever wondered how to communicate your science so that EVERYONE understands what you do? At the CUNYSciCom Symposium, grad students compete to explain their research as clearly as possible to general & scientific audiences. This free event is at ASRC in NYC on May 27 2026. Use QR code to register.

Happy to share our new work with @haognguyen on targeting mRNA translation of oncogenes by RNA structure remodeling with a small molecule zotatifin. Congrats to ⁦@DuyguKuzuoglu⁩ an amazing postdoc and all the authors and collaborators! cell.com/cancer-cell/fu…

Daraxonrasib median OS 13.2 months vs. 6.7 for chemotherapy. Phase 3 randomized controlled trial. I'm so happy. ir.revmed.com/news-release...

Cap-independent translation by 4E-BP1, eIF4E, eIF4GI-eIF4A Differential regulation of CITE-like (4EBP1-sensitive, HIF1α, p53A) versus IRES-like mechanisms (4EBP1-resistant, FGF9, p53B) Fluorescence Anisotropy for protein-RNA binding #JBC 2025 www.jbc.org/article/S002...

EPA - Environmental Pollution Agency. Oh, how far we have fallen. www.nbcnews.com/science/clim...

Pretty good summary of the forces arrayed against the CO2 endangerment finding. I think they are counting their chickens prematurely. 🎁 www.nytimes.com/2026/02/09/c...

Very excited to share a new research article from my lab about the biology of EGFR glycosylation that was published in the journal Cancers today. Congrats to all the authors! www.mdpi.com/3706608

The New York Research and Mentoring for Postbaccalaureates (NY-RaMP) program is recruiting! If you are a current college senior or recent graduate interested in 1 year of paid scientific research in NYC, more info about NY-RaMP and the application due on Feb 18 is available at nyramp.org

Hunter College’s Department of Biological Sciences has a new open rank faculty search: cuny.jobs/new-york-ny/...

📢 SIGN & SHARE THE PETITION! 📢 New York needs an Empire Biomedical Research Institute to create new statewide funding opportunities for scientists & physician-scientists so that patients and their families get the life-saving and life-changing new therapeutics they're hoping for ✏️ c.org/TDMy2H9JTW

Exciting new finding about the role of PP2A molecular glues in overcoming resistant to broad classes of MAPK inhibitors in KRAS driven cancers JCI - A PP2A molecular glue overcomes ras/mapk inhibitor resistance in kras-mutant non-small cell lung cancer www.jci.org/articles/vie...

Huge congrats to this year’s cohort of @damonrunyon SPARK postbacs -- especially @huntercollege alumni Subyeta Chowdhury and NY-RaMP alumni Imani Williams! damonrunyon.org/news/entries/8337/Damon%20Runyon%20announces%20newest%20class%20of%20SPARK%20Scholars

Damon Runyon mentor-mentee duo Piro Lito, MD, PhD, and Antonio Cuevas-Navarro, PhD, have developed a new approach to treating RAS-driven cancers, such as colorectal and pancreatic. Rather than inhibiting the cancerous protein, their drug restores its natural function. Read more:

Great stuff! Hunter College osteosarcoma researcher Shahana Mahajan has published a paper with new findings that have possible applications to many types of cancers. More: journals.plos.org/plosone/arti... #MihiCuraFuturi

See How E.V. Road Trips Went From Impossible to Easy www.nytimes.com/interactive/...

Encouraging phase 1 results of an off-the-shelf, lymph node targeted #cancer vaccine targeting common #KRAS mutations (G12D, G12R) in pancreatic and colorectal cancer from Elicio $ELTX, @mskcancercenter.bsky.social, @mdanderson.bsky.social‪‬, UCLA & clinical collabs www.nature.com/articles/s41...

Congratulations to our @obenaufa.bsky.social on receiving the highly prestigious Dr. Josef Steiner Cancer Research Award 2025! 🎉 Read more in this interview with Anna: www.imp.ac.at/news/article...

I am thrilled that our findings about using the Ras inhibitor daraxonrasib against osteosarcoma were just published in PLOS ONE! Many congrats to my co-authors Okkeun Jung, Angelene Soto, and Shahana Mahajan. dx.plos.org/10.1371/jour...

The federal government’s demand of $1 billion from @UCLA would devastate the nation’s best public university, cut off life-saving care, halt tech and economic growth and reduce educational access. Stand with UC to protect our vital mission: www.universityofcalifornia.edu/get-involved...

Exciting work!

@cuny.edu Research in Focus looks at the work of Hunter College’s Climatologist and Professor of Geography and Environmental Science, William Solecki, who shows how we can design our public spaces to mitigate global warming. Read about it here: www.cuny.edu/news/resilie...

Congratulations and bon voyage to Hunter College alumni Sajida Ahmed, Alison Juray, Andrew Loka, and Alp Doymaz, who will be traveling all over the world during the 2025 - 2026 academic year through the Fulbright Program! #HunterPride hunter.cuny.edu/news/four-fr...

Excited to share our recent work published in PNAS last week uncovering the molecular mechanisms of PARP inhibitor resistance in BRCA2-deficient metastatic castration-resistant prostate cancer (mCRPC). Check out our manuscript!

Our amazing lab team, Spring 2025! A huge congratulations to the lab members about to earn their undergraduate degree, finish their postbaccalaureate program, begin graduate school, and begin medical school.

Very excited that this work was published in PNAS today! www.pnas.org/doi/10.1073/...

Huge congratulations to Dr. Melinda Diver and her lab on the publication of this outstanding new study, "Transport and InsP8 gating mechanisms of the human inorganic phosphate exporter XPR1" in the journal Nature Communications today! www.nature.com/articles/s41...

I am thrilled that our review about the RNA-binding protein IMP2 was published today! Congratulations to my co-authors Jessica Das, Ottavia Busia-Bourdain, and Khizr Khan. doi.org/10.3390/ijms...

A long-awaited nonopioid pain drug has won approval from the U.S. Food and Drug Administration (FDA) to treat moderate to severe short-term pain.

Recent studies provide new insights into signaling by mutant KRAS, inhibitors of which have provided modest benefits for patients. Learn more in a new Clinical Implications of Basic Research article: nej.md/4aia1Bv #MedSky #Oncology

A new post in Science Careers for our open-rank faculty search at the Hunter College Dept of Biological Sciences: jobs.sciencecareers.org/job/668588/o...

It's been a delight to be a Mentor to a Postbac Scholar in Damon Runyon SPARK this year. College seniors interested in paid full time cancer research next year - I encourage you to apply to SPARK. @damonrunyon.org damonrunyon.org/for-scientists/application-guidelines/research

Do you love science and want research experience before your next step? NY-RaMP is a 1 year paid opportunity for recent college graduates to do research in my lab or another lab at Hunter College. Learn more at a free webinar on Wed Dec 11 at 3 PM EST nyramp.org/webinars

Cancer researchers: Are you a postdoc ready to launch your own lab? Or an Assistant/Associate/Full Professor seeking a change of scene? The Biological Sciences dept at Hunter College in New York City is hiring! Apply to our new open rank faculty search: bit.ly/huntercollegebiology

What an amazing team!